Shares of Rhoen Klinikum AG (ETR:RHK) have earned a consensus rating of “Hold” from the nine brokerages that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell rating and six have given a hold rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is €24.06 ($28.31).

RHK has been the topic of several research reports. Commerzbank Ag set a €25.00 ($29.41) price objective on shares of Rhoen Klinikum AG and gave the company a “neutral” rating in a report on Thursday, August 3rd. Baader Bank set a €24.00 ($28.24) price objective on shares of Rhoen Klinikum AG and gave the company a “neutral” rating in a report on Thursday, August 3rd. Warburg Research set a €26.00 ($30.59) price objective on shares of Rhoen Klinikum AG and gave the company a “neutral” rating in a report on Thursday, August 3rd. Independent Research GmbH set a €28.00 ($32.94) price objective on shares of Rhoen Klinikum AG and gave the company a “neutral” rating in a report on Monday, August 14th. Finally, Berenberg Bank set a €26.50 ($31.18) price target on shares of Rhoen Klinikum AG and gave the company a “neutral” rating in a research note on Monday, August 7th.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/17/rhoen-klinikum-ag-rhk-given-average-rating-of-hold-by-brokerages.html.

Shares of Rhoen Klinikum AG (ETR:RHK) opened at 29.109 on Tuesday. The company has a market capitalization of €1.95 billion and a P/E ratio of 454.828. Rhoen Klinikum AG has a one year low of €22.91 and a one year high of €29.20. The firm has a 50-day moving average of €28.39 and a 200-day moving average of €26.79.

Rhoen Klinikum AG Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhoen Klinikum AG (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related companies with MarketBeat.com's FREE daily email newsletter.